Page 8 - Dr Reddy's
South Korean firm sues Dr Reddy's in US court
Mezzion Pharma accuses Dr Reddy's of fraud by hiding significant deficiencies in CGMP regulations
 "South Korean firm sues Dr Reddy's in US court")
Dr Reddy's launches osteoporosis drug in US market
It launched Raloxifene hydrochloride tablets in 60 mg
 "Dr Reddy's launches osteoporosis drug in US market")
Dr Reddy's Foundation launches new skill development initiative
Under the new model designed to be more impactful and self-sustainable, DRF has inaugurated 110 centres across the country
 "Dr Reddy's Foundation launches new skill development initiative")
Dr Reddy's launches Nitroglycerin tablets in the US
A medicine that opens blood vessels to improve blood flow, used to treat patients complaining of chest pain among other symptoms
 "Dr Reddy's launches Nitroglycerin tablets in the US")
Dr Reddy's gets nod to export 15 drugs to EU
The order will enable the company to import these substances for a period of three years, ending June 2019
 "Dr Reddy's gets nod to export 15 drugs to EU")
Dr Reddy's delivers a bitter pill
Higher competition led to poor performance even as three plants remained under the US FDA scanner
 "Dr Reddy's delivers a bitter pill")
Dr Reddy's completes Rs 1,569.41 crore share buyback
In February this year, the company's board had approved a proposal to buyback shares
Growth challenges remain for Dr Reddy's
Acquisition of drug applications positive, but resolution of US regulatory issues holds key
Dr Reddy's buys 8 US drugs from Teva, Allergan for $350 million
The combined sales of the branded versions of the products in the US is about $3.5 bn
 "Dr Reddy's buys 8 US drugs from Teva, Allergan for $350 million")
US Consumer Product Safety Commission seeks action against Dr Reddy's
Panel alleges drug maker failed to report a 'non-compliance, defect, unreasonable risk' relating to blister packs as is legally required
 "US Consumer Product Safety Commission seeks action against Dr Reddy's")
Dr Reddy's re-draws new drug plan
Unlike in the past, when it tried to produce its own molecule, this time the company is licensing these from abroad
 "Dr Reddy's re-draws new drug plan")
Dr Reddy's launches psoriasis treatment spray
A prescription topical steroid approved by the USFDA in February, 2016
Dr Reddy's: Weak Q4, uncertainties remain
Venezuelan adjustments hit results. Plants under US scanner; slow India growth; hence, prospects subdued
Dr Reddy's Q4 net down 85% at Rs 75 cr
Provisioning to write down receivables from Venezuela, higher tax expenses and decrease in revenues impacted the company's profits
 "Dr Reddy's Q4 net down 85% at Rs 75 cr")
Dr Reddy's signs US licensing agreement with XenoPort
The drug major will pay an upfront fee of $50 million (Rs 335 crore) to XenoPort
 "Dr Reddy's signs US licensing agreement with XenoPort")
